InCoB 2020 Keynote and Plenary Speakers
Yoshihiro KawaokaProfessor University of Winsconsin-Madison, USA
Dr. Yoshihiro Kawaoka was educated in Japan, receiving his DVM in 1978 and his PhD in 1983 from Hokkaido University. He established the technique of reverse genetics, which allows the generation of ‘designer’ influenza viruses. This technology was used to develop the flu vaccine FluMist® and candidate bird flu vaccines. Dr. Kawaoka discovered what makes bird flu viruses so deadly and how they jump from birds to humans. In addition to his influenza research, Dr. Kawaoka also studies Ebola virus. His group worked in Sierra Leone during the 2014–2016 Ebola outbreak and continues to work with Ebola survivors. He is currently developing an Ebola vaccine, which entered clinical trials in 2019. In February 2020, he initiated research on SARS-CoV-2
including developing viral assays and establishing animal models of infection In recognition of his achievements, Dr. Kawaoka was awarded the Robert Koch Award in 2006; he received the Medal of Honor (Purple Ribbon) in 2011 and the Japan Academy Award in 2016 from the Emperor of Japan for his influenza research. In 2013, he was elected as an international member of the United States National Academy of Sciences. In 2015, he received the UNESCO Carlos J. Finlay Prize for Microbiology.
Title: SARS-CoV-2: what we have learned so far (Yoshihiro Kawaoka, DVM, PhD, University of Wisconsin-Madison; University of Tokyo)
Late in 2019, a new coronavirus emerged in Wuhan, China and spread worldwide. The causative virus, SARS-CoV-2, continues to have a devastating impact on human lives. In an effort to develop therapeutics and preventive measures, we are performing numerous research projects with this virus. In this presentation, I will discuss our findings regarding animal models and vaccine development.